The Ideal Cease and Desist Letter - Informative and Only Covertly Threatening?
The oft-used cease and desist letter ("C&D letter") may have significant implications for both intellectual property ("IP") owner and alleged infringer alike. Although the test for an improper C&D letter may be well-established, there have been relatively few cases where such letters have been held to be improper, and no reported cases dealing with actual quantification of resulting damages. This fact, combined with the reality that interlocutory injunctions remain a difficult remedy to obtain in Canada, may very well mean that IP owners should consider taking the risk of sending out threatening communications to an infringer's customers. In certain circumstances, improper/threatening letters may practically provide IP owners with a remedy that is otherwise unattainable in Canada, and the closest thing to an interlocutory injunction. At the same time, lawyers must be vigilant to ensure IP owners are aware of the risks of sending unlawful cease and desist letters. Lawyers themselves should also ensure compliance with ethical obligations regarding due diligence evaluations that should be conducted prior to sending out any such letters (whether improperly threatening or not).
Analysis
A recent (and perhaps rare) example of an impeacher successfully bringing a misleading advertising claim against an unsuccessful patentee aptly illustrates the particular circumstances that assist in making such a claim. In Excalibre Oil Tools Ltd. v Advantage Products Inc.[1], the court found the patentee had violated section 7(a) of the Trade-marks Act by sending overtly threatening letters to Excalibre's mining customers. Section 7(a) states:
7. No person shall
(a) make a false or misleading statement tending to discredit the business, wares or services of a competitor;
The seminal C&D case from the Supreme Court of Canada ("SCC"), S & S Industries Inc. v Rowell[2], established the test for section 7(a) as follows:
Significantly, this SCC decision held that no malice was required for section 7(a) (unlike common law actions of injurious falsehoods and trade libel). The court rationalized that an abusive patentee without malice should not be permitted to avoid the "forthright course" (of actually carrying out a lawsuit) and instead rely on empty threats against a purchaser. The SCC found a section 7(a) violation[3] based on a warning notice in a magazine following settlement of an infringement case against a bra wire customer, and warning letters to a customer:
You are hereby advised that unless you inform us within the week that you will immediately cease and desist from the manufacture, sale and use of such flat arcuate wires for use in brassieres, you will leave us with no other alternative but to forward the matter to my Canadian associates for institution of legal proceedings for infringement of the aforesaid patent. Your reply is awaited.
...
that in order that we may best protect our interests, we would be forced to go to the stores and involve them in law suits
The patented products in Excalibre related to mining production accessories (anchors) that assist with pump stability. The court easily characterized the patentee API's letters as "contain[ing] explicit threats of litigation":
API demands Husky immediately cease sourcing the CTA torque anchor. Husky is encouraged to review the attached SOC and assess their own liability in this infringement of API's exclusive rights. ... Should Husky choose to continue along their current path, API will be compelled to amend their litigation to include Husky.
...
The Canadian Patent Act also provides API with similar right [sic] of enforcement against purchasers and as against users of patented torque anchors which are not obtained from authorized sources, including Bronco Energy. ... Unless Bronco Energy advises this office, by May 23rd, of their immediate cessation of the above infringing activities, API will amend their litigation to include Bronco Energy.
Causation, often the more difficult requirement, was also met. Fact witnesses indicated these letters resulted in them no longer purchasing the impeacher CTA's product. "There is an indisputable nexus arising between the impugned letters and resulting loss of business and damage, even if unquantified, to the Excalibre Parties." A significant factor in finding such a nexus was the particular industry. The mining business was characterized as particularly litigation adverse. One customer (interestingly who was not subpoenaed, such that presumably impeacher Excalibre was aware of what he would say in advance) was involved in drilling on native reserves at the time. They testified "they could not afford interruptions in business or bad publicity". Another customer, Husky, appeared to be the "ideal" customer for a section 7(a) claim resulting from a cease and desist letter. Husky (under subpoena) indicated it was "very litigation averse and that its legal strategy was to take the easiest, most non-confrontational route, because the company did not want to spend any money on litigation". Indemnification would not even have changed Husky's decision to stop purchasing the impeacher's product.
Calculation of the actual damages resulting from Excalibre's lost sales over the applicable 8.5 year period are to be determined in a separate reference. As is often the case it is expected, assuming the decision is upheld on the pending appeal, that the parties will settle such quantum issues in advance of a second hearing/summary trial type proceeding. Notably the court refused to include the impeacher's other accessory mining products in the damages reference as these were "far too remote". As part of this analysis, the court was critical of the absence of mitigation efforts regarding these other accessory products.
Aside from the business consequences of threatening your own potential customers, an IP owner may want to evaluate the positives regarding cease and desist letters, and balance this against the risks associated with more strongly worded letters.
Practice Point
Several practical points may be gleaned from the C&D jurisprudence that should be considered.
From an impeacher/infringer perspective:
From an IP owner perspective:
"As these doors were a complete copy of our patented Re-Coil-Away Rolling Rubber Door system, we commenced legal action for patent infringement at that time."[9]
"You know, even though we talked internally in terms of the stress of the threats, that wasn't the reason why we made the decision"[11]
This article was also published on SLAW online magazine.
[1] 2016 FC 1279 (Justice Manson) [under appeal A-460-16]
[2] [1966] SCR 419 at 424 ("S&S")
[3] Actual quantum for the 7(a) violation was deferred to a separate reference, which appears to have settled.
[4] E Mishan & Sons, Inc v Supertek Canada Inc, 2016 FC 986 (Hughes)
[5] E Mishan & Sons, Inc v Supertek Canada Inc, 2016 FC 986 (Hughes)
[6] See for example, Professor Siebrasse's concern that one should not have to wait for actual damage to bring a section 7(a) case [http://www.sufficientdescription.com/2016/12/are-damages-element-of-claim-under.html].
[7] Although such an injunction was ordered (enjoining a patentee from making further statements it had made 3 years ago to customers alleging its patent was infringed), after the court found the patent was invalid and not infringed. (Riello Canada Inc v Lambert (1986) 9 CPR(3d) 324 (FCTD))
[8] Uview Ultraviolet Systems Inc v Brasscorp Ltd, 2009 FC 58 (O'Keefe) [regarding a press release advising of the pending infringement action; the 7(a) claim was denied because existence of damages was not proven]; see also M.K. Plastics Corp. v. Plasticair Inc.2007 FC 574
[9] M&I Door Systems Ltd v Indoro Industrial Door Co Ltd (1989), 25 CPR (3d) 477 (FCTD), (Cullen)
[10] For example, Tearlab Corporation v I-Med Pharma Inc. 2017 FCA 8 has reinforced the difficulty in obtaining injunctions in patent infringement cases because "patent rights are economic in nature" and therefore damages are quantifiable "“ there is no irreparable harm.
[11] E Mishan & Sons, Inc v Supertek Canada Inc, 2016 FC 986 (Hughes)
* This article was written by Paula Bremner, Paula is a registered Canadian patent and trademark agent who was a member of Aird & McBurney LP. Paula’s practice covers a variety of aspects of intellectual property law, with a focus on litigation. She specializes in pharmaceutical patent litigation, particularly in the context of the Patented Medicines (Notice of Compliance) Regulations. For more information, please contact Kitt Sinden at ksinden@airdmcburney.com.